Bausch Health Companies (BHC) Short-term Investments (2009 - 2026)

Bausch Health Companies has disclosed Short-term Investments across 14 years of filings, most recently posting $13.0 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $13.0 million, down 43.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.0 million (down 43.48% YoY), and the FY2025 annual result was $16.0 million, down 20.0% from the prior year.
• Short-term Investments came in at $13.0 million for Q1 2026 at Bausch Health Companies, down from $16.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $1.2 billion in Q2 2022 to a low of $9.0 million in Q2 2023.
• The 5-year median for Short-term Investments is $20.0 million (2023), against an average of $160.4 million.
• Across the five-year window, Short-term Investments plunged 99.26% in 2023 and soared 211.11% in 2024, its largest moves.
• Bausch Health Companies' Short-term Investments stood at $27.0 million in 2022, then sank by 44.44% to $15.0 million in 2023, then surged by 33.33% to $20.0 million in 2024, then retreated by 20.0% to $16.0 million in 2025, then dropped by 18.75% to $13.0 million in 2026.
• The last three Short-term Investments figures came in at $13.0 million (Q1 2026), $16.0 million (Q4 2025), and $32.0 million (Q3 2025), per Business Quant data.